$LAB
STANDARD BIOTOOLS INC. Stock $lab

$lab Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000116219420000107 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$44.61M	$39.86M	$26.50M
YoY Change	37.51%	50.44%	-8.52%
Cost Of Revenue	$18.39M	$14.54M	$12.46M
YoY Change	26.4%	16.71%	-5.2%
Gross Profit	$22.08M	$20.80M	$13.84M
YoY Change	25.89%	50.3%	-12.54%
Gross Profit Margin	49.5%	52.18%	52.23%
Selling, General & Admin	$31.94M	$22.66M	$20.73M
YoY Change	69.96%	9.29%	3.54%
% of Gross Profit	144.64%	108.92%	149.8%
Research & Development	$11.19M	$8.128M	$7.125M
YoY Change	35.14%	14.08%	-4.1%
% of Gross Profit	50.68%	39.08%	51.49%
Depreciation & Amortization	$15.92M	$3.960M	$3.930M
YoY Change	305.19%	0.76%	336.67%
% of Gross Profit	72.12%	19.04%	28.4%
Operating Expenses	$43.12M	$45.33M	$40.31M
YoY Change	59.29%	12.44%	46.86%
Operating Profit	-$21.04M	-$5.464M	-$13.82M
YoY Change	120.75%	-60.45%	18.82%
Interest Expense	-$890.0K	$885.0K	$444.0K
YoY Change	39.06%	99.32%	-88.95%
% of Operating Profit
Other Income/Expense, Net	$755.0K	$107.0K	$205.0K
YoY Change	48.04%	-47.8%	75.21%
Pretax Income	-$17.04M	-$6.242M	-$14.06M
YoY Change	38.19%	-55.59%	-9.5%
Income Tax	$987.0K	-$200.0K	-$1.200M
% Of Pretax Income
Net Earnings	-$18.03M	-$5.999M	-$12.89M
YoY Change	42.05%	-53.45%	-12.63%
Net Earnings / Revenue	-40.41%	-15.05%	-48.64%
Basic Earnings Per Share		-$0.08
Diluted Earnings Per Share	-$242.6K	-$0.08	-$0.19
COMMON SHARES
Basic Shares Outstanding	74.12M shares	72.49M shares	69.40M shares
Diluted Shares Outstanding		72.49M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$68.52M	$72.30M	$62.80M
YoY Change	16.93%	15.13%	75.42%
Cash & Equivalents	$68.52M	$72.35M	$25.89M
Short-Term Investments	$0.00	$0.00	$36.90M
Other Short-Term Assets	$4.031M	$5.700M	$4.800M
YoY Change	-12.37%	18.75%	118.18%
Inventory	$19.69M	$19.56M	$15.00M
Prepaid Expenses
Receivables	$25.42M	$17.61M	$14.01M
Other Receivables	$0.00	$7.500M	$0.00
Total Short-Term Assets	$117.7M	$122.7M	$96.55M
YoY Change	22.44%	27.04%	34.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.53M	$7.531M	$8.396M
YoY Change	117.61%	-10.3%	-13.98%
Goodwill	$106.6M	$106.5M	$104.1M
YoY Change	2.36%	2.25%	0.0%
Intangibles	$40.21M	$42.96M	$49.00M
YoY Change	-12.97%	-12.34%	-18.6%
Long-Term Investments
YoY Change
Other Assets	$4.680M	$4.904M	$5.984M
YoY Change	-14.79%	-18.05%	-5.94%
Total Long-Term Assets	$207.1M	$200.3M	$172.8M
YoY Change	22.75%	15.9%	-4.21%
TOTAL ASSETS
Total Short-Term Assets	$117.7M	$122.7M	$96.55M
Total Long-Term Assets	$207.1M	$200.3M	$172.8M
Total Assets	$324.8M	$323.0M	$269.4M
YoY Change	22.64%	19.89%	6.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.220M	$10.97M	$5.339M
YoY Change	78.96%	105.49%	-14.52%
Accrued Expenses	$11.88M	$6.565M	$5.105M
YoY Change	33.91%	28.6%	-22.44%
Deferred Revenue	$13.48M	$13.44M	$11.94M
YoY Change	14.17%	12.55%	3.71%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.25M	$42.79M	$33.37M
YoY Change	65.29%	28.25%	-14.15%
LONG-TERM LIABILITIES
Long-Term Debt	$54.22M	$54.10M	$49.90M
YoY Change	0.79%	8.42%	-70.53%
Other Long-Term Liabilities	$1.333M	$536.0K	$473.0K
YoY Change	132.64%	13.32%	-78.23%
Total Long-Term Liabilities	$1.333M	$536.0K	$473.0K
YoY Change	132.64%	13.32%	-78.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.25M	$42.79M	$33.37M
Total Long-Term Liabilities	$1.333M	$536.0K	$473.0K
Total Liabilities	$185.7M	$171.0M	$106.8M
YoY Change	67.0%	60.13%	-53.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$676.8M	-$658.7M	-$611.0M
YoY Change	8.52%	7.82%	12.29%
Common Stock	$75.00K	$74.00K	$70.00K
YoY Change	7.14%	5.71%	79.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$139.1M	$152.0M	$162.6M
YoY Change
Total Liabilities & Shareholders Equity	$324.8M	$323.0M	$269.4M
YoY Change	22.64%	19.89%	6.78%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$18.03M	-$5.999M	-$12.89M
YoY Change	42.05%	-53.45%	-12.63%
Depreciation, Depletion And Amortization	$15.92M	$3.960M	$3.930M
YoY Change	305.19%	0.76%	336.67%
Cash From Operating Activities	-$15.42M	-$4.590M	-$4.550M
YoY Change	179.29%	0.88%	12.07%
INVESTING ACTIVITIES
Capital Expenditures	-$12.72M	$340.0K	$1.340M
YoY Change	-2643.4%	-74.63%	570.0%
Acquisitions
YoY Change
Other Investing Activities	$52.69M	$13.55M	$7.890M
YoY Change	-105484.0%	71.74%	689.0%
Cash From Investing Activities	$39.98M	$13.21M	$6.550M
YoY Change	-7368.18%	101.68%	718.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.86M	20.42M	-180.0K
YoY Change	1071.74%	-11444.44%	28.57%
NET CHANGE
Cash From Operating Activities	-15.42M	-4.590M	-4.550M
Cash From Investing Activities	39.98M	13.21M	6.550M
Cash From Financing Activities	20.86M	20.42M	-180.0K
Net Change In Cash	45.42M	29.04M	1.820M
YoY Change	-1158.62%	1495.6%	-153.53%
FREE CASH FLOW
Cash From Operating Activities	-$15.42M	-$4.590M	-$4.550M
Capital Expenditures	-$12.72M	$340.0K	$1.340M
Free Cash Flow	-$2.700M	-$4.930M	-$5.890M
YoY Change	-55.15%	-16.3%	38.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001162194
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3M
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-34180
	dei	Entity Registrant Name EntityRegistrantName	FLUIDIGM CORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0513190
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Tower Place, Ste 2000
	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	266-6000
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	FLDM
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	74119005	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72345000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21661000	USD
CY2020Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	36978000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	324000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17613000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18981000	USD
CY2020Q3	fldm	Research And Development Arrangement Receivables ResearchAndDevelopmentArrangementReceivables	7456000	USD
CY2019Q4	fldm	Research And Development Arrangement Receivables ResearchAndDevelopmentArrangementReceivables	0	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	19560000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	13884000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5689000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4592000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	122663000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	96096000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7531000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8056000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38469000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4860000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4904000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5492000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42955000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46200000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	106455000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	104108000	USD
CY2020Q3	us-gaap	Assets Assets	322977000	USD
CY2019Q4	us-gaap	Assets Assets	264812000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10971000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6510000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9122000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5160000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2697000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1833000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6565000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7515000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13436000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11803000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	42791000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32821000	USD
CY2020Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	54121000	USD
CY2019Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	53821000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9041000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11494000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38607000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4323000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7684000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8168000	USD
CY2020Q3	fldm	Deferred Grant Revenue Noncurrent DeferredGrantRevenueNoncurrent	18224000	USD
CY2019Q4	fldm	Deferred Grant Revenue Noncurrent DeferredGrantRevenueNoncurrent	0	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	536000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	573000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	171004000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	111200000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74115000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74115000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69956000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69956000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	74000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	70000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	810923000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	777765000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-289000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-582000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-658735000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-623641000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	151973000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	153612000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	322977000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	264812000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39861000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26496000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93536000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84803000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8128000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7125000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25275000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23362000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22655000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20729000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65966000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65687000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	45325000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	40312000	USD
	us-gaap	Operating Expenses OperatingExpenses	127668000	USD
	us-gaap	Operating Expenses OperatingExpenses	127461000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5464000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13816000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-34132000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-42658000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	885000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	444000	USD
	us-gaap	Interest Expense InterestExpense	2682000	USD
	us-gaap	Interest Expense InterestExpense	3636000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9000000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	107000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	205000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-248000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	920000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6242000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14055000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-37062000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-54374000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-243000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1168000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2068000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2269000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-5999000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-12887000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-52105000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.79
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	72486000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69469000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	71294000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	65792000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-5999000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-12887000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-52105000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	523000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-121000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	329000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-122000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-14000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-36000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	51000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	520000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-135000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	293000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-71000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5479000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13022000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34701000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52176000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	153612000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-146000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2364000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2049000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-15980000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-303000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	141496000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-116000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	645000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3633000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-13015000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	76000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	132719000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-123000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	450000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20228000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	180000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4358000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-5999000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	520000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	151973000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	72116000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	133298000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-176000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	255000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2207000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-25465000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	182245000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-325000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	793000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	641000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2985000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-13753000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	54000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	172640000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-69000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3055000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-12887000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-135000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	162605000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-34994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-52105000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	2988000	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3484000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10358000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8292000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8929000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8400000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	415000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2130000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1863000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	-371000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9000000	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	680000	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1356000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-191000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-52000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	13000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	195000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-967000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3195000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5154000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6773000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3672000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2395000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1338000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4996000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	605000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1258000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1592000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-180000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-10506000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11684000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29691000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	52719000	USD
	fldm	Proceeds From Research And Development Grant ProceedsFromResearchAndDevelopmentGrant	11151000	USD
	fldm	Proceeds From Research And Development Grant ProceedsFromResearchAndDevelopmentGrant	0	USD
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	5010000	USD
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	31800000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	16000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2010000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2031000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	40797000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38750000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20226000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	509000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	128000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	450000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1049000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	645000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	641000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	387000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	556000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20425000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1006000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49624000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67440000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23736000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95401000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73360000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27961000	USD
	us-gaap	Interest Paid Net InterestPaidNet	86000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3513000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	386000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	128000	USD
	fldm	Asset Retirement Obligations Incurred But Not Yet Paid AssetRetirementObligationsIncurredButNotYetPaid	319000	USD
	fldm	Asset Retirement Obligations Incurred But Not Yet Paid AssetRetirementObligationsIncurredButNotYetPaid	311000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain prior period amounts in the condensed consolidated statements of income and condensed consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders’ equity, total revenue, total costs and expenses, loss from operations or net loss.
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information in the context of information available to us and the unknown impact of COVID-19 as of September 30, 2020. These accounting matters included, but were not limited to, our allowance for doubtful accounts and credit losses, inventory and related reserves and the carrying value of goodwill and other long-lived assets. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements.</span></div>
CY2020Q1	us-gaap	Legal Fees LegalFees	400000	USD
	fldm	Product Warranty Term ProductWarrantyTerm	P1Y
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Business and Credit Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. One customer from whom we derived development revenue exceeded 10% of revenue for the three and nine months ended September 30, 2020. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020 or 2019. Including the development revenue, revenues from our five largest customers were 31% and 25% </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue for the three months ended September 30, 2020 and 2019, respectively. Revenues from our five largest customers were 23% and 20% of total revenue for the nine months ended September 30, 2020 and 2019, respectively. There was no single customer that represented more than 10% of total accounts receivable at September 30, 2020, or December 31, 2019.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div>
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Maximum Contract Value ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue	34000000.0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-303000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	76000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	520000	USD
	fldm	Research And Development Arrangement Contract To Perform For Others Liquidated Damages Term ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesTerm	P6M
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27463000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6258000	shares
CY2020Q1	us-gaap	Share Price SharePrice	4.22
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Maximum Contract Value ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue	34000000.0	USD
	fldm	Research And Development Arrangement Contract To Perform For Others Liquidated Damages Percentage ResearchAndDevelopmentArrangementContractToPerformForOthersLiquidatedDamagesPercentage	0.33
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Amount ResearchAndDevelopmentArrangementContractToPerformForOthersAmount	18607000	USD
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Expenses ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses	383000	USD
CY2020Q3	fldm	Deferred Grant Revenue Noncurrent DeferredGrantRevenueNoncurrent	18224000	USD
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Amount ResearchAndDevelopmentArrangementContractToPerformForOthersAmount	18607000	USD
CY2020Q3	fldm	Research And Development Arrangement Contract To Perform For Others Funding Received ResearchAndDevelopmentArrangementContractToPerformForOthersFundingReceived	11151000	USD
CY2020Q3	fldm	Research And Development Arrangement Receivables ResearchAndDevelopmentArrangementReceivables	7456000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39861000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26496000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93536000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84803000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39861000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26496000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	93536000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84803000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000000.0	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8800000	USD
	fldm	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	9900000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21100000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3873000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10385000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5775000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4079000	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	24112000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3207000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12671000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	12588000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12482000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2118000	USD
CY2020Q3	fldm	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	2133000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45199000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72345000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21661000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1015000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2075000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73360000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23736000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	15000	USD
CY2020Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1000000.0	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8768000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6133000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	920000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	659000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9872000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7092000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	19560000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	13884000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33680000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32934000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26262000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24954000	USD
CY2020Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	113000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	76000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7531000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8056000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1390000	USD
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	863000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	677000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	912000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	387000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	668000	USD
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1680000	USD
CY2019Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1107000	USD
CY2020Q2	fldm	Debt Instrument Early Redemption Cost Percent Of Maximum Borrowing Capacity DebtInstrumentEarlyRedemptionCostPercentOfMaximumBorrowingCapacity	0.0025
CY2020Q2	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	112500	USD
CY2020Q3	fldm	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	41392000	USD
CY2019Q4	fldm	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	6658000	USD
CY2020Q3	fldm	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2923000	USD
CY2019Q4	fldm	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1798000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38469000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4860000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2697000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1833000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38607000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4323000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41304000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6156000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y10M24D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.119
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	2501000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1604000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	7012000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	4660000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	407000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	748000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	1576000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	2051000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3443000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3068000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1802000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7362000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7040000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6950000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7152000	USD
CY2020Q3	fldm	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	39254000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	69560000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28256000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41304000	USD
CY2020Q3	fldm	Cash Cash Equivalents And Short Term Investments Amortized Cost CashCashEquivalentsAndShortTermInvestmentsAmortizedCost	73360000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	73360000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72345000	USD
CY2020Q3	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1015000	USD
CY2019Q4	fldm	Cash Cash Equivalents And Short Term Investments Amortized Cost CashCashEquivalentsAndShortTermInvestmentsAmortizedCost	60678000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	36000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	60714000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21661000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	36978000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2075000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0	investment
CY2020Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6157000	shares
CY2020Q3	fldm	Sharebased Compensation Arrangementby Sharebased Payment Award Vesting Restrictions Ownership Percentageof Voting Stock SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock	0.10
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2027000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.78
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	81000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	105000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.74
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	98000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	352000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	408000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.20
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1626000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y4M24D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2514000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1259000	shares
CY2020Q3	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice	7.86
	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne	P6Y
CY2020Q3	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue	1799000	USD
	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber	367000	shares
CY2020Q3	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice	5.56
	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1	P7Y10M24D
CY2020Q3	fldm	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	715000	USD
CY2020Q3	us-gaap	Share Price SharePrice	7.43
CY2019Q2	fldm	Employee Stock Purchase Plan Offering Period EmployeeStockPurchasePlanOfferingPeriod	P6M
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2019Q2	fldm	Employee Stock Purchase Plan Offering Period EmployeeStockPurchasePlanOfferingPeriod	P12M
CY2020Q2	fldm	Employee Stock Purchase Plan Number Of Six Month Offering Periods EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods	2	offering_period
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2020Q2	fldm	Employee Stock Purchase Plan Number Of Six Month Offering Periods EmployeeStockPurchasePlanNumberOfSixMonthOfferingPeriods	2	offering_period
CY2020Q2	fldm	Employee Stock Purchase Plan Offering Period EmployeeStockPurchasePlanOfferingPeriod	P6M
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4357000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3029000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10358000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8292000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2100000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1200000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2300000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020Q3	fldm	Up Front And Milestone Payments Maximum UpFrontAndMilestonePaymentsMaximum	11700000	USD
	fldm	Collaborative Arrangement Term CollaborativeArrangementTerm	P1Y

Files In Submission

Name	View Source	Status
0001162194-20-000107-index-headers.html	Edgar Link	pending
0001162194-20-000107-index.html	Edgar Link	pending
0001162194-20-000107.txt	Edgar Link	pending
0001162194-20-000107-xbrl.zip	Edgar Link	pending
exhibit101to3q20orm.htm	Edgar Link	pending
exhibit10210q3q2020.htm	Edgar Link	pending
exhibit102a10q3q2020.htm	Edgar Link	pending
exhibit10310q3q2020.htm	Edgar Link	pending
exhibit103a10q3q2020.htm	Edgar Link	pending
exhibit10410q3q2020.htm	Edgar Link	pending
exhibit10510q3q2020.htm	Edgar Link	pending
exhibit10610q3q2020.htm	Edgar Link	pending
exhibit31110q3q2020ng.htm	Edgar Link	pending
exhibit31210q3q2020ng.htm	Edgar Link	pending
exhibit32110q3q2020ng.htm	Edgar Link	pending
exhibit32210q3q2020ng.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
fldm-20200930.htm	Edgar Link	pending
fldm-20200930.xsd	Edgar Link	pending
fldm-20200930_cal.xml	Edgar Link	unprocessable
fldm-20200930_def.xml	Edgar Link	unprocessable
fldm-20200930_g1.jpg	Edgar Link	pending
fldm-20200930_htm.xml	Edgar Link	completed
fldm-20200930_lab.xml	Edgar Link	unprocessable
fldm-20200930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LAB
STANDARD BIOTOOLS INC. Stock $lab

2020 Q4 Form 10-Q Financial Statement

#000116219420000107 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAB STANDARD BIOTOOLS INC. Stock $lab

2020 Q4 Form 10-Q Financial Statement

#000116219420000107 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAB
STANDARD BIOTOOLS INC. Stock $lab